Home
Scholarly Works
NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE...
Conference

NIVOLUMAB AND IPILIMUMAB IN FIRST-LINE NON-SMALL-CELL LUNG CARCINOMA (NSCLC): INTERIM PHASE I RESULTS

Authors

Antonia SJ; Gettinger S; Chow LQ; Juergens R; Borghaei H; Shen Y; Harbison C; Chen AC; Ready NE; Rizvi NA

Volume

10

Pagination

pp. 155-155

Publisher

WILEY-BLACKWELL

Publication Date

December 1, 2014

Conference proceedings

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

ISSN

1743-7555

Labels

Fields of Research (FoR)

Contact the Experts team